Extract Or Material Containing Or Obtained From A Multicellular Fungus As Active Ingredient (e.g., Mushroom, Filamentous Fungus, Fungal Spore, Hyphae, Mycelium, Etc.) Patents (Class 424/195.15)
  • Patent number: 10426804
    Abstract: A pentosidine production inhibitor including a lactic acid bacterium fermentation product as an active ingredient, which has a stronger action and a high safety as a component having an action of inhibiting production of pentosidine.
    Type: Grant
    Filed: June 25, 2014
    Date of Patent: October 1, 2019
    Assignee: Kabushiki Kaisha Yakult Honsha
    Inventors: Naoki Izawa, Daisuke Niwa, Toshiro Sone
  • Patent number: 10413556
    Abstract: A method of inducing the production of insulin in the body by an individual smelling a composition of a solution including testosterone, and inducing the production of insulin in the body of the individual. A method of treating diabetes type 2 by an individual having diabetes type 2 smelling a composition of a solution including testosterone, inducing the production of insulin in the body of the individual, and treating diabetes type 2 in the individual.
    Type: Grant
    Filed: March 21, 2019
    Date of Patent: September 17, 2019
    Inventor: Moshe Shifrine
  • Patent number: 10357525
    Abstract: Disclosed herein is a novel use of a polysaccharide mixture for the treatment of hyperglycemia and/or disorders related thereto (e.g., diabetes mellitus). The polysaccharide mixture comprises about 30-50% (wt %) of ?(1?3) glucan and ?(1?6) glucan, and has a molecular weight of at least 500,000. The polysaccharide mixture may be administered to a subject suffering from hyperglycemia in a dose of about 1 to 1,000 mg/Kg to ameliorate or alleviate symptoms associated with hyperglycemia.
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: July 23, 2019
    Assignee: TRINEO BIOTECHNOLOGY CO. LTD
    Inventors: Cheng-Po Huang, Cheng-Chiu Tsao, Chao-hsuan Chang, Teng-Hai Chen, Li-Ming Huang, Chieh-Hung Lin
  • Patent number: 10342843
    Abstract: Therapeutic compositions for addressing physiological stresses and aging include an immune modulator and one or more adaptogenic nutrients. Some non-limiting examples of immune modulators include as transfer factor, low molecular weight fraction immune modulators and/or other low molecular weight fractions of colostrum, egg or any other source of transfer factor or low molecular weight fraction immune modulators. Methods for administering immune modulators and adaptogenic nutrients to a subject to address the effects of physiological stresses and aging in the body of the subject, such as inflammatory responses, are also disclosed.
    Type: Grant
    Filed: February 14, 2017
    Date of Patent: July 9, 2019
    Assignee: 4Life Patents, LLC
    Inventor: Christopher M. Lockwood
  • Patent number: 10322158
    Abstract: A therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires insulin resistance, including administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum (Hematite), Magnetitum (Magnetite), radix Achyranthis Bidentatae (Achyranthes bidentata), rhizoma Dioscoreae (Dioscoreae Rhizoma), radix Paeoniae Rubra (Paeoniae Radix Rubra), radix Rehmanniae (Rehmannia), and semen Platycladi (Platycladi Semen).
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: June 18, 2019
    Inventor: Chen-Yu Lee
  • Patent number: 10322157
    Abstract: The present invention is directed to a therapeutic method of treatment of diabetes mellitus, particularly diabetes which acquires multiple drug resistance, comprising administering a therapeutically effective amount of Chinese herbal medicine to a subject in need. The Chinese herbal medicine is the decocting extract including the mixture of raw oyster shell powder, raw Os Draconis, Haematitum, Magnetitum, radix Achyranthis Bidentatae, rhizoma Dioscoreae, radix Paeoniae Rubra, radix Rehmanniae, and semen Platycladi.
    Type: Grant
    Filed: July 6, 2017
    Date of Patent: June 18, 2019
    Inventor: Chen-Yu Lee
  • Patent number: 10307470
    Abstract: Immunogenic compositions, cancer vaccines and methods for treating cancer comprising FMS, the fucose-enriched polysaccharide fraction from Reishi F3, are provided. Compositions comprise fucose-enriched Reishi polysaccharide fraction (FMS) MW=˜35 kDa, wherein the FMS is isolated by size-exclusion chromatography from Reishi F3, and the FMS comprises polysaccharides having primarily a backbone selected from 1,4-mannan and 1,6-?-galactan, wherein the backbone is linked to a terminal fucose-containing side-chain Immunogenic compositions comprising glycolipid adjuvants are provided. Antibodies generated by immunogenic compositions disclosed herein bind cancer cells comprising antigens Globo H, Globo H, Gb3, Gb4, Gb5 (SSEA-3) and SSEA-4 on the cell surface.
    Type: Grant
    Filed: July 26, 2014
    Date of Patent: June 4, 2019
    Assignee: ACADEMIA SINICA
    Inventors: Chi-Huey Wong, Chung-Yi Wu, Hsien-Yeh Hsu, Shih-Fen Liao, Chi-Hui Liang
  • Patent number: 10293033
    Abstract: The present invention relates to a proteolytic extract obtained from bromelain for the treatment of connective tissue diseases. In particular, the present invention relates to a pharmaceutical composition comprising a proteolytic extract obtained from bromelain for the treatment of diseases such as Dupuytren's disease and Peyronie's disease.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: May 21, 2019
    Assignee: MediWound Ltd.
    Inventors: Lior Rosenberg, Guy Rubin, Eilon Asculai
  • Patent number: 10238702
    Abstract: The pharmaceutical composition is a formulation prepared by the raw materials in parts by weight: 1-300 parts of chlorogenic acid and 1-50 parts of Ganoderma lucidum spore oil, and the preparative process for said pharmaceutical composition was provided. Chlorogenic acid can be used compatibly with Ganoderma lucidum spore oil, with a synergistic effect. Inclusion technique is applied in product development to improve stability of oily liquid material Ganoderma lucidum spore oil and solid material chlorogenic acid obtained from the extract of Eucommia leaves. After inclusion by the inclusion technology, the liquid drugs become powder, and thus easily oxidized natural products could be protected. Moreover, the damage for active ingredients caused by air can be prevented, and the stability and the taste may get improved.
    Type: Grant
    Filed: August 21, 2013
    Date of Patent: March 26, 2019
    Assignee: SICHUAN JIUZHANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Jie Zhang, Huarong Yang, Chenxu Tian, Lina Zhu, Wang Huang, Yongjiang Yan
  • Patent number: 10226493
    Abstract: The subject invention provides Coriolus versicolor extracts, pharmaceutical compositions comprising the Coriolus versicolor extracts, methods of preparation, and therapeutic uses thereof. Advantageously, the subject Coriolus versicolor extract has immunomodulatory, anti-tumor, anti-microbial, and antiviral effects. In a preferred embodiment, the subject invention can be used to inhibit the metastatic spread of cancer cells. In certain preferred embodiments, the subject invention can be used to treat glioblastoma multiforme, nasopharyngeal carcinoma, breast carcinoma, lung carcinoma, prostate cancer, and colon carcinoma, as well as bacterial, viral, fungal, protozoan, and/or other microbial infection.
    Type: Grant
    Filed: October 6, 2011
    Date of Patent: March 12, 2019
    Assignees: BAGI RESEARCH LIMITED, VERSITECH LIMITED
    Inventors: Stanley Chi Chung Chik, Anna Hing-Yee Law, Cindy Lai Hung Yang, Maureen Lau
  • Patent number: 10131488
    Abstract: Described herein is an aerosol hairspray product including a container including a container wall which encloses a reservoir. The reservoir includes from about 40% to about 70% of a hairstyling formulation and from about 30% to about 60% of a dimethyl ether propellant. The hairstyling formulation includes water, one or more hairstyling polymers, and from about 0.05% to about 2% alcohol. A spraying device is attached to the container. The spraying devices includes a valve including a valve housing including a vapor tap including a vapor tap area. A dip tube is connected to the valve. The dip tube includes a dip tube orifice including a dip tube orifice area. The ratio of the vapor tap area to the dip tube orifice area is from about 0.005 to about 0.15.
    Type: Grant
    Filed: June 1, 2016
    Date of Patent: November 20, 2018
    Assignee: The Procter and Gamble Company
    Inventors: Jodi Lee Brown, William Mercer Benson, Jose Antonio Carballada
  • Patent number: 10131716
    Abstract: The present invention provides a method for manufacturing fungal pharmaceutical composition, used for extracting a glycosaminoglycan fiber from a fungal cell wall. Differing from the glycosaminoglycan fiber produced by using a fabrication method proposed by Taiwan patent No. 442496 showing many drawbacks including low extraction percentage, coarse fiber, and having light-yellow color, the glycosaminoglycan fiber manufactured by using this novel method reveals the advantages of high extraction percentage, fine fibers, and showing white color. So that, the novel glycosaminoglycan fiber produced by using the present invention's method is suitable for being processed to an excipient.
    Type: Grant
    Filed: December 20, 2016
    Date of Patent: November 20, 2018
    Assignees: Taiwan Indigena Botanica Co., Ltd., Taipei Medical University
    Inventors: Cheng-Jeng Tai, Yeu-Ching Shi, Fang-Mo Chang, Ching-Hua Su
  • Patent number: 9872494
    Abstract: The present invention relates to novel active ingredient combinations which consist of fluopyram and other known active ingredients and are very well suited for the control of animal pests, such as insects and/or unwanted acarids and/or nematodes, in foliar and soil application and/or in the treatment of seeds, and are also suitable for increasing yields.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: January 23, 2018
    Assignee: BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Heike Hungenberg, Heiko Rieck, Robert Masters
  • Patent number: 9820443
    Abstract: Disclosed herein is an industrial scale process of cultivating cultivating Ganoderma lucidum mycelia. As high as 15 Kg dried Ganoderma lucidum mycelia may be produced from about 300 liters liquid culture every 30 days, and the resulting dried Ganoderma lucidum mycelia are rich in triterpenoids that include at least ganoderic acid S (GAS), ganoderic acid T (GAT), ganoderic acid Me (GAMe), ganoderic acid R (GAR), and ganodermic acid S (GMAS).
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: November 21, 2017
    Assignee: DOUBLE CRANE BIOTECHNOLOGY CO. LTD.
    Inventors: Li-Ming Huang, Chih-Wei Chen, Mon-Tarng Chen, Yen-Chun Liu, Kuang-Dee Chen
  • Patent number: 9795810
    Abstract: The present invention relates to a stick type composition comprising propylene glycol, glycerin and water.
    Type: Grant
    Filed: September 30, 2008
    Date of Patent: October 24, 2017
    Assignee: COLGATE-PALMOLIVE COMPANY
    Inventors: Christopher T. Chappell, Stefan Gafner, Anne Gale, Nick Holerca, Jennifer L. Lafrance, Steve Misner
  • Patent number: 9788567
    Abstract: To provide a production technique for an edible egg that contains a sufficient amount of ergothioneine by using the biological accumulation of the ergothioneine in eggs, and that has antioxidative activity. This ergothioneine-containing egg is obtained from a hen raised by being fed a hen feed for a prescribed time period, the hen feed being manufactured by manufacturing the ergothioneine-containing extract solution from a waste medium used in the production of edible mushrooms and mixing a prescribed amount of the extract solution into a feed for the hen used generally.
    Type: Grant
    Filed: November 20, 2014
    Date of Patent: October 17, 2017
    Assignees: ORIGIN BIOTECHNOLOGY KABUSHIKIKAISHA, KABUSHIKIKAISHA HOKKEN
    Inventors: Kazunari Abe, Toshiaki Ohshima, Rikuo Fukui
  • Patent number: 9717769
    Abstract: The present invention relates to a method for protecting a kidney, which comprises administering an extracellular polysaccharide produced by Ceriporia lacerata; a mycelial culture medium of Ceriporia lacerata containing the extracellular polysaccharide; dried powders of the mycelial culture medium; or an extract of the mycelial culture medium, in an effective amount, to a subject in need of protecting a kidney. The method is effective in protecting a kidney from renal toxicity caused by an anti-cancer agent.
    Type: Grant
    Filed: November 25, 2016
    Date of Patent: August 1, 2017
    Assignee: FUGENBIOPHARMA CO., LTD.
    Inventors: Yoon Soo Kim, Hye Dong Yoo, Eun Ji Shin
  • Patent number: 9623053
    Abstract: The present invention belongs to a pharmaceutical composition preparation field of traditional Chinese medicine, and more particularly relates to a pharmaceutical composition for treating AIDS and preparation method thereof. The pharmaceutical composition of the present invention for treating AIDS comprises the following raw medicinal materials: Cordyceps Sinensis in an amount of 3-6 parts by weight, Dried Radix Rehmanniae in an amount of 4-12 parts by weight, Mylabris in an amount of 1-3 parts by weight, and Rhizoma Anemarrhenae in an amount of 3-6 parts by weight. The clinical trials show that the pharmaceutical composition has a relatively good therapeutic effect for treating AIDS.
    Type: Grant
    Filed: December 31, 2013
    Date of Patent: April 18, 2017
    Inventor: Zhonglin Wang
  • Patent number: 9592183
    Abstract: An inhibitor of endothelin action or a skin-whitening agent, comprising a compound represented by Formula (1) or a salt thereof as an active ingredient: wherein in Formula (1), R1 represents a formyl group or an alkyl group having 1 to 4 carbon atom(s), and R2 represents a hydrogen atom or an alkyl group having 1 to 4 carbon atom(s).
    Type: Grant
    Filed: November 24, 2011
    Date of Patent: March 14, 2017
    Assignee: Kao Corporation
    Inventors: Tsuyoshi Ohba, Daiki Murase, Mitsuru Sugiyama
  • Patent number: 9585927
    Abstract: The invention provides a composition comprising a mixture of extracts obtained from Atractylodes macrocephala, Astragalus membranaceus, Taraxacum mongolicum, Poria cocos, Ligusticum chuanxiong, Ligustrum lucidum, Codonopsis pilosula, Glycyrrhiza uralensis, Hedyotis diffusa, Pseudostellaria heterophylla, and Viola philippica. The present invention further provides a method for treating metastatic breast cancer in a subject in need thereof, comprising: administering to said subject an pharmaceutically effective amount of the composition.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: March 7, 2017
    Assignee: MERIYANA BIO MANAGEMENT B.V.
    Inventor: Chih Hui Lin
  • Patent number: 9572847
    Abstract: The invention discloses an herbal extract of treating lung tumor. The herbal extract comprises Antrodia cinnamomea and Cordyceps militaris, and the herbal extract is manufactured as following: mingling Antrodia cinnamomea and Cordyceps militaris with a weight ratio being between 1:5 and 5:1 to obtain a mixture; blending the mixture with a solvent with a weight-volume percentage being 50%, followed by extracting at 40-90° C. to obtain a herbal solution; and concentrating the herbal solution to obtain the herbal extract.
    Type: Grant
    Filed: December 23, 2013
    Date of Patent: February 21, 2017
    Assignee: Kingland Property Corporation, Ltd.
    Inventors: Wei-Cheng Chen, Mei-Chou Lai, Shorong-Shii Liou, I-Min Liu
  • Patent number: 9498508
    Abstract: A pharmaceutical composition for treating cancers and preparation method thereof. Said composition for treating cancers contains Chinese medicinal materials including Rhizoma Pinelliae, Rhizoma Arisaematis, Rhizoma Gastrodiae etc., and said preparation method is in accordance with a conventional Chinese medicinal preparation method, manufacturing said composition to form any one of the ordinary oral preparations.
    Type: Grant
    Filed: September 6, 2015
    Date of Patent: November 22, 2016
    Inventor: Mingchun Xiao
  • Patent number: 9399050
    Abstract: The present invention utilizes the pre-sporulation (preconidial) mycelial stage of entomopathogenic fungi and extracts of the preconidial mycelium as insect and arthropod attractants and/or pathogens. The preconidial preparations can be employed to limit the zoonotic and plant diseases they transmit. The fungus can be cultivated on grain, wood, agricultural wastes or other cellulosic material and extracts can be made thereof. More than one fungus and substrate can be used in combination with one or more antimicrobial, antiprotozoal, antiviral, or genetically modified agents that result in reduced spread of contagions and lessens the damage they inflict on animals and plants.
    Type: Grant
    Filed: June 20, 2013
    Date of Patent: July 26, 2016
    Inventor: Paul Edward Stamets
  • Patent number: 9365481
    Abstract: Provided herein are processes of preparing cyclohexenone compounds useful for cancer treatments and/or diseases.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: June 14, 2016
    Assignee: Golden Biotechnology Corporation
    Inventors: Sheng-Yung Liu, Wu-Che Wen, Chih-Ming Chen, Hsiu-Yi Cheng
  • Patent number: 9272010
    Abstract: The invention discloses an herbal extract of treating liver cancer, wherein a method of producing the herbal extract comprising the steps of: blending Antrodia cinnamomea, Rhinacanthus nasutus and Phellinus linteus and obtaining a mixture, wherein the weight percentages of Antrodia cinnamomea, Rhinacanthus nasutus and Phellinus linteus are 33.4 to 60%, 20 to 33.4% and 20 to 33.4% by weight of the mixture, respectively; soaking the mixture with a 95% ethanol solution with a weight-volume percentage being 50%, followed by extracting at 50 to 80° C.; and concentrating the extracted product to obtain the herbal extract. The invention also discloses a method of treating liver cancer.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: March 1, 2016
    Assignee: KINGLAND REAL ESTATE CO., LTD.
    Inventors: Wei-Cheng Chen, Mei-Chou Lai, Shorong-Shii Liou, I-Min Liu
  • Patent number: 9185849
    Abstract: A solid medium of Antrodia cinnamomea comprises 20 to 50 wt % soybean; 30 to 50 wt % coixseed; and 20 to 50 wt % sorghum. A culturing method of Antrodia cinnamomea, comprises providing a solid medium comprising soybean, coixseed and sorghum; preparing a solution of Antrodia cinnamomea, inoculating the solution of Antrodia cinnamomea on the solid medium in a concentration of 1×103 to 1×106 cfu on per 100 g of solid medium, and statically culturing the solution of Antrodia cinnamomea on the solid medium till obtaining hyphae adhered on the solid medium; and culturing the solution of Antrodia cinnamomea by intermittent shaking in a frequency of every 5 to 7 days shaking 5 to 10 minutes, with a period of the culturing by intermittent shaking being more than 40 days.
    Type: Grant
    Filed: December 18, 2012
    Date of Patent: November 17, 2015
    Inventors: Po-Lun Wang, Jung-Chi Hsieh, Ting-Yuan Lai, Jui-Lung Cheng
  • Patent number: 9179693
    Abstract: A method for improving the performance of a subject or for improving digestibility of a raw material in a feed (e.g. nutrient digestibility, such as amino acid digestibility), or for improving nitrogen retention, or for improving dietary phosphorus absorption and retention, or for improving the efficacy of the phytase, or for improving the subject's resistance to necrotic enteritis or for improving feed conversion ratio (FCR) or for improving weight gain in a subject or for improving feed efficiency in a subject or for modulating (e.g. improving) the immune response of the subject or for reducing populations of pathogenic bacteria in the gastrointestinal tract of a subject, or for reducing nutrient excretion in manure, which method comprising administering to a subject at least one direct fed microbial in combination with a phytase, wherein the phytase is administered to the subject at a dosage of more than about 1500 FTU/kg feed.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 10, 2015
    Assignee: DuPont Nutrition Biosciences ApS
    Inventors: Luis Romero, Peter Plumstead, Luke Barnard
  • Patent number: 9161959
    Abstract: Use of a vegetable drug composition in the manufacturing of a pharmaceutical preparation for the treatment of portal hypertension caused by hepatocirrhosis, said preparation comprises 25-38% of extract of radix Salviae Miltiorrhizae, 20-25% of extract of herb Gynostemmae Pentaphylli, 1-6% of alcoholic extract of fructus Schisandrae Chinensis, 19-26% of extract of Cordyceps, 6-8% of extract of pollen Pini, 6-10% of extract of semen Persicae. Said preparation can improve hepatic cell degeneration, necrosis, intraheptic hemorrhage, fiber proliferation, and reduce pressure of portal vein in mammal. A preparation method of said preparation is disclosed.
    Type: Grant
    Filed: April 28, 2008
    Date of Patent: October 20, 2015
    Assignee: SHANGHAI SUNDISE CHINESE MEDICINE TECHNOLOGY DEVELOPMENT CO., LTD
    Inventors: Lieming Xu, Cheng Liu, Ping Liu
  • Patent number: 9144542
    Abstract: A composition for promoting hair growth in humans can include at least three of the following ingredients: Pygeum Africanum, Serenoa Repens, Ganoderma Lucidum, Piper Methysticum, and Zinc. The amount by weight of the identified ingredients in a particular formulation may range from at least 5% to no more than 50% of the formulation.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: September 29, 2015
    Assignee: Kay Jay, LLC
    Inventor: Kevin Meehan
  • Patent number: 9138450
    Abstract: The present invention provides methods for treating constipation-predominant irritable bowel syndrome comprising administering to a patient in need thereof, a polymeric proanthocyanidin composition from a Croton species or Calophyllum species in an amount sufficient to treat constipation-predominant irritable bowel syndrome (c-IBS). Treatment of c-IBS includes the treatment of the constipation component of c-IBS as well as the pain and abdominal discomfort associated with c-IBS. In one embodiment, the polymeric proanthocyanidin compound is crofelemer. The present invention in an alternative embodiment also provides methods for treating alternating constipation-predominant/diarrhea-predominant irritable bowel syndrome.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: September 22, 2015
    Assignee: Napo Pharmaceuticals, Inc.
    Inventors: Barry D. Quart, David P. Rosenbaum
  • Patent number: 9095143
    Abstract: A method for producing an antimicrobial agent, by cutting, or cutting and then milling a plant belonging to the family Juncaceae: mixing the cut plant with a nutrient source for a seed culture of mushroom mycelia, to form a mixture; inoculating the seed culture of mycelia to the mixture of the plant belonging to the family Juncaceae and the nutrient source and then culturing the seed culture at a growth temperature for the seed culture of mycelia to produce the antimicrobial agent.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: August 4, 2015
    Assignee: KABUSHIKI KAISHA OUJU SEIYAKU
    Inventors: Masayoshi Iwahara, Hiroshi Morita, Kazuyuki Miyata
  • Patent number: 9084736
    Abstract: The present invention relates to the use of an extract of Lentinus, as well as the pharmaceutical composition that contains it, within the scope of combating cellulite and subcutaneous accumulations of fat.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: July 21, 2015
    Assignee: Caster
    Inventors: Jean-Christophe Choulot, Patrick Ales
  • Patent number: 9060963
    Abstract: Methods and compositions for reducing and/or inhibiting inflammation by topical application of dermatocosmetic compositions comprising effective amounts of extracts of Coriolus versicolor that have been hydrolyzed by an acid protease, preferably Rhizomucor miehei, and thereafter rendered substantially devoid of acid-protease activity.
    Type: Grant
    Filed: December 14, 2011
    Date of Patent: June 23, 2015
    Assignee: Active Organics, Inc.
    Inventors: Michael Bishop, Elysiann Bishop, Walter Smith, Glen Gillis
  • Patent number: 9056897
    Abstract: The present invention relates to a method for isolating acyclohexapeptide and to a novel crystalline form of caspofungin diacetate thus obtained.
    Type: Grant
    Filed: September 26, 2011
    Date of Patent: June 16, 2015
    Assignee: DSM SINOCHEM PHARMACEUTICALS
    Inventors: Robertus Mattheus De Pater, Dhiredj Chandre Jagesar
  • Publication number: 20150147352
    Abstract: The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The invention also relates to the combination of sulforaphane or a derivative thereof and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The present invention also relates to the combination of a broccoli extract or powder and a mushroom (preferably maitake, shiitake, or reishi mushroom) extract or powder. The present provides compositions and methods relating to these combinations.
    Type: Application
    Filed: July 3, 2013
    Publication date: May 28, 2015
    Inventors: Brian Cornblatt, Grace Cornblatt, Anton Bzhelyansky, Robert Henderson
  • Publication number: 20150147351
    Abstract: The present invention relates to use of a composition in the manufacture of health care products or medicaments for prevention and treatment of allergic diseases. The composition is made from raw materials comprising 5 to 200 parts by weight of Ganoderma, 5 to 150 parts by weight of Radix Panacis Quinquefolii or Radix Et Rhizoma Ginseng, 1 to 90 parts by weight of fermented Cordyceps sinensis powder and/or 1 to 120 parts by weight of Cordyceps, or is a composition made from water and/or alcohol extracts of the above raw materials as active components. The allergic diseases include allergic rhinitis, allergic dermatitis, urticaria, and/or allergic asthma.
    Type: Application
    Filed: May 27, 2013
    Publication date: May 28, 2015
    Inventors: Hongguang Zhong, Minzhi Yi, Jianzhong Lu
  • Publication number: 20150140029
    Abstract: Disclosed are the action and use of water extracts and polysaccharides from Fusarium oxysporums in immune enhancement, which belong to the field of biological pharmacy. The water extracts and polysaccharides from Fusarium oxysporums have a significant immune enhancement effect, which can promote the proliferation of macrophages, increase the phagocytic ability of macrophages, activate macrophages to release immunological active factors NO, IL-1? and TNF-? and can be used in lower immune function diseases and tumor adjuvant treatment.
    Type: Application
    Filed: February 1, 2013
    Publication date: May 21, 2015
    Applicant: University of Macau, Av. Padre Tomas Pereira Taipa
    Inventors: Shaoping Li, Kun Feng, Lanzhen Meng, Jing Zhao
  • Publication number: 20150132280
    Abstract: A human dietary supplement comprises theacrine and optionally other compounds that modulate the effects of theacrine. Uses for the theacrine-containing supplement include improvement of at least one of mood, energy, focus, concentration or sexual desire or a reduction of at least one of anxiety or fatigue.
    Type: Application
    Filed: November 12, 2014
    Publication date: May 14, 2015
    Applicant: ORTHO-NUTRA, LLC
    Inventors: Hector L Lopez, Shawn Wells, Tim N. Ziegenfuss
  • Publication number: 20150125484
    Abstract: A composition for promoting hair growth is provided with fermented and distilled extracts of fermented and distilled extracts of ganoderma, fungus, grapes, sorghum, wheat, onions, ginger, burdock, aloe vera, carrot, rose, litsea, tea, whip grass, incense, sage, blue citrus, bergamot, rosmarinus officinalis, sesame oil tree, nutmeg, rosewood, orange, marigold, geranium, and honey flower. The composition can be made into shampoo.
    Type: Application
    Filed: November 4, 2013
    Publication date: May 7, 2015
    Applicants: Li Ren Wang, Hua Guan Bio-tech Corporation
    Inventor: Li Ren Wang
  • Publication number: 20150104426
    Abstract: Disclosed is a composition for skin external application containing a Pleurotus ferulae fruiting body extract, a Pleurotus ferulae mycelium extract or a liquid culture obtained by culturing the Pleurotus ferulae mycelium. More specifically, disclosed is a functional composition for skin external application containing 0.001 to 90.0% by weight of a Pleurotus ferulae fruiting body extract, a Pleurotus ferulae mycelium extract or a liquid culture obtained by culturing the Pleurotus ferulae mycelium, with respect to the weight of the composition, wherein the composition is potently effective in scavenging active oxygen, preventing aging, acting wrinkles, facilitating collagen synthesis, moisturizing skin, whitening skin, reducing skin irritation, preventing acne, alleviating atopy, providing anti-inflammation, preventing hair damage, preventing alopecia and improving hair growth.
    Type: Application
    Filed: January 27, 2014
    Publication date: April 16, 2015
    Applicant: AMI Cosmetic Co., Ltd.
    Inventors: Kyung Rok Lee, Il Hong, Do Gyeong Lee, Jung No Lee, Soo Yeon Choi, Nu Rim Lee
  • Publication number: 20150093409
    Abstract: The present invention relates to topical compositions containing fermented extracts of Traditional Chinese Medicinal (TCM) ingredients for improving the appearance and skin condition of the user. The topical compositions of the present invention are tailored for different users of different skin compositions according to TCM principles. The fermented TCM extracts are characterized by reduced odor and/or color in comparison with unfermented TCM extracts and are therefore more suitable for use in cosmetic products.
    Type: Application
    Filed: October 1, 2013
    Publication date: April 2, 2015
    Inventors: Jing Cheng, Chia-Wen Chen, Steven Francis Schnittger, Ming Lu
  • Patent number: 8986758
    Abstract: Disclosed are: a method for extracting a traditional herbal medicine component comprising a process in which a traditional oriental medicine component is steamed together with polished rice; and a composition for an external application to skin comprising an extract which has been extracted by means of the method. The component extracted by means of the extraction method reduces the cytotoxicity of the traditional oriental medicine, is recognized as being effective in alleviating skin irritation, and exhibits an outstanding skin-whitening effect.
    Type: Grant
    Filed: November 17, 2010
    Date of Patent: March 24, 2015
    Assignee: Amorepacific Corporation
    Inventors: Dong Hyun Kim, Ji Seong Kim, Hui Kyeung Chang, Duck Hee Kim, Han Kon Kim
  • Patent number: 8986756
    Abstract: The present invention is related to a combined herb composition comprising herbs of Coriolus versicolor, Astragalus membranaceus Bunge, and additionally comprising at least one herb selected from group consisting of Schisandra chinensis, and Artemisia capillaris, according to the need for the prevention and treatment of liver disease and methods of using the above crude drug composition and pharmaceutical composition as hepato-protective agent.
    Type: Grant
    Filed: December 18, 2007
    Date of Patent: March 24, 2015
    Inventor: Jung Sik Lee
  • Publication number: 20150079128
    Abstract: This invention relates to a Chinese medicinal formulation for the treatment of inflammatory bowel diseases, and a method of preparation thereof. The formulation comprises herbal components selected from a group consisting of Radix Codonopsis (Dangshen), Rhizoma Atractylodis Macrocephalae (Bai Zhu), Sclerotium Poriae Cocos (Fu Ling), Rhizoma Zingiberis Officinalis (Gan Jiang), Radix Paeoniae Alba (Bai Shao) and Rhizoma Coptidis (Huanglian).
    Type: Application
    Filed: September 18, 2013
    Publication date: March 19, 2015
    Applicant: Hong Kong Baptist University
    Inventors: Zhaoxiang Bian, Siu Wai Tsang, Siu Po Ip, Che Yuen Justin Wu, Aiping Lu, Albert Sun Chi Chan
  • Publication number: 20150050323
    Abstract: Disclosed herein are inventive stable homogenized biomass hetero-colloids, their production and uses. Such biomass hetero-colloids comprise biomass derived solid particle colloid matter and at least 15% (w/w) biomass derived soluble colloid matter. The novel biomass hetero-colloids provide an inventive approach for the application of biologically active compounds. Bio-actives are made available in an innovative form involving low intervention processing and enhancing the biological availability.
    Type: Application
    Filed: April 19, 2013
    Publication date: February 19, 2015
    Inventor: Othmar KAEPPELI
  • Publication number: 20150050315
    Abstract: The disclosure provides a method for modulating Th17 cells, including: administering an Antrodia cinnamomea (also named Antrodia camphorata or Taiwanofungus camphoratus) extract to a subject in need thereof, wherein the Antrodia cinnamomea extract has an effect of modulating Th17 cells. The Antrodia cinnamomea extract may include a fruiting body extract of Antrodia cinnamomea or a mycelium extract of Antrodia cinnamomea.
    Type: Application
    Filed: July 3, 2014
    Publication date: February 19, 2015
    Inventors: I-Horng PAN, Shu-Fang WEN, Ming-Han LI, Hsin-Jan YAO, Hsin-Chieh WU, I-Huang LU, Joung-Liang LAN, Der-Yuan CHEN, Chi-Chien LIN, Ching LU
  • Patent number: 8956624
    Abstract: Compositions for treating skin containing at least one extract from the genus Trametes and at least one viscosity enhancing synthetic polymer, and methods for whitening skin, treating skin for improvement, or treating skin disorders associated with pigmentation such as uneven pigmentation, skin mottling, or age spots or other dermatological disorders such as eczema, rosacea, hyperkeratinization, and so on.
    Type: Grant
    Filed: November 21, 2008
    Date of Patent: February 17, 2015
    Assignee: ELC Management, LLC
    Inventors: Steven F. Schnittger, Daniel H. Maes, Michael Sullivan
  • Publication number: 20150023906
    Abstract: A powder plant treatment formulation for application to plants by insect vectoring includes: a plant treatment agent; a stabilizing agent bonded to the plant treatment agent for stabilizing the plant treatment agent; a moisture absorption agent for absorbing moisture from the formulation; an attracting agent for attracting the formulation to plants; and a diluent.
    Type: Application
    Filed: September 11, 2014
    Publication date: January 22, 2015
    Applicant: BEE VECTORING TECHNOLOGY INC.
    Inventors: Todd Gordon Mason, John Clifford Sutton
  • Patent number: 8936788
    Abstract: A method and container for developing seedlings includes germinating the seeds and air pruning the seedlings to a depth of about 3 inches.
    Type: Grant
    Filed: June 7, 2013
    Date of Patent: January 20, 2015
    Assignee: Wayne Lovelace and Judy Lovelace
    Inventors: Wayne Lovelace, Hugh Steavenson, Bob Suddarth
  • Publication number: 20150017203
    Abstract: A combination product includes as active substances, at least an inhibitor of the HMG-CoA-reductase enzyme and citrulline, or a bioequivalent compound thereof, for treating excess weight or obesity and/or the accumulation of body fat. A cosmetic treatment method for improving or slimming the figure and/or for stimulating the loss of excess weight and/or of cellulite and/or for limiting the accumulation thereof, includes the administration of a combination product including as active substances, at least an inhibitor of the HMG-CoA-reductase enzyme or a physiologically acceptable salt thereof, and citrulline, or a bioequivalent compound thereof, or one of theirs analogues, and the renewal of the administration until the expected cosmetic effect is obtained. The combination product such as previously defined for improving or slimming the figure and/or for stimulating the loss of excess weight and/or of cellulite and/or for limiting the accumulation thereof is also described.
    Type: Application
    Filed: February 28, 2013
    Publication date: January 15, 2015
    Applicants: UNIVERSITE PARIS DESCARTES, ASSISTANCE PUBLIQUE HOPITAUX DE PARIS, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE - INRA
    Inventors: Beatrice Morio-Liondore, Frederic Capel, Jean-Pascal De Bandt, Christophe Moinard, Luc Cynober